International
Studies reveal how the Lunit SCOPE® suite identifies immunotherapy-responsive subtypes, standardizes immune phenotyping, and accelerates antibody-based target discovery SEOUL, South Korea, November 7, 2025 — Lunit (KRX:328130.KQ), a...
From Backlogs to Rapid Diagnosis: Diagnexia Secures Full UKAS Accreditation for End-to-End Histopathology OXFORD, UK – 04/11/2025 – Responding to increasing demand for reliable pathology reporting across the NHS, Diagnexia UK Limited...
Proscia: Top clinical teaching hospital is laying the foundation for AI-driven disease diagnosis and research HAARLEM, Netherlands and PHILADELPHIA – October 27, 2025 – Spaarne Gasthuis, a top clinical teaching hospital serving part of...
Aiforia Technologies Plc, Press Release, October 22, 2025 at 10:30 a.m. EEST Aiforia Technologies, a leading Finnish provider of deep learning AI solutions for digital pathology, has entered into a local agreement with Siemens Healthineers...
Aiforia: A significant milestone in enhancing workflows and improving diagnostic quality and consistency in their pathology laboratory. Aiforia Technologies Plc, Press Release, October 13, 2025, at 10:00 a.m. EEST Aiforia Technologies’...
The Future of Precision Medicine Starts at the Moment of Diagnosis OCTOBER 28, 2025 | 11:30AM ET | VIRTUAL EVENT Join Access25 on October 28 to discover how Proscia is removing one of the biggest barriers to realizing precision...
